Cardiovascular Disease
Almost 1 in 5 Australians have a long term cardiovascular condition.
Whilst death rates have fallen, with the positive impact of public health campaigns, cardiovascular disease remains the leading cause of death in Australia.
Hormones play a key role in the healthy functioning of the cardiovascular system. PHI researchers are focusing on fundamental molecular understandings as well as clinical applications.
These PHI Laboratories have a focus on cardiovascular disease:
Cardiovascular Endocrinology is studying hormones involved in the cardiovascular system.
Steroid Receptor Biology is working to develop clinical guidelines and more effective treatments for cardiovascular disease.
Clinical Andrology is testing if a hormone boost in older men with low testosterone can reduce their cardiovascular risk.